CSIMarket Company Name, Ticker, Suppliers, else..
 
Champions Oncology Inc   (NASDAQ: CSBR)
 
Price: $5.2200 $-0.06 -1.136%
Day's High: $5.409999847412109 Week Perf: 4.4 %
Day's Low: $ 5.08 30 Day Perf: 0.58 %
Volume (M): 10,919 52 Wk High: $ 8.74
Volume (M$): $ 0 52 Wk Avg: $6.21
Open: $5.28 52 Wk Low: $4.83



 Market Capitalization (Millions $) 72
 Shares Outstanding (Millions) 14
 Employees 214
 Revenues (TTM) (Millions $) 59
 Net Income (TTM) (Millions $) -1
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 1

Business Description


Champions Oncology Inc is a biotechnology company that specializes in developing and providing personalized medicine solutions for cancer patients. The company offers services that include creating patient-derived tumor xenograft (PDX) models, which are used for drug testing and development. These PDX models are derived directly from patients' tumors and aim to replicate the complexity and diversity of the original tumor biology, allowing for more accurate and personalized treatment approaches. Champions Oncology's services also include biomarker analysis, genetic profiling, and drug sensitivity testing. The company collaborates with pharmaceutical and biotechnology companies to advance the development of new cancer therapies.


   Company Address: One University Plaza, Suite 307 Hackensack 7601 NJ
   Company Phone Number: 808-8400   Stock Exchange / Ticker: NASDAQ CSBR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ADPT   -3.61%    
RGNX   -7.45%    
SNSE        28.34% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.22
Price to Sales (Expected) -
Price to Book 17.75
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.24
Working Capital Ratio 1.34
Leverage Ratio (MRQ) 5.67
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.08 $
Revenues (TTM) 4.3 $
Cash Flow (TTM) -
Cash 0.35 $
Book Value 0.29 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 277,687
Net Income per Employee (TTM) -5,776
Receivable Turnover Ratio (TTM) 5.23
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 1.73

Profitability Ratios Current
Gross Margin (MRQ) 50.79 %
Operating Margin (MRQ) -3.77 %
Net Margin (MRQ) -5.26 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Champions Oncology Inc's Segments
Pharmacology services    412.93 % of total Revenue
Translational Oncology Solutions (tos) License Revenue    5.52 % of total Revenue
Product and Service, Other    11.04 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.